Can oxcarbazepine cause memory loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Oxcarbazepine Cause Memory Loss?

Oxcarbazepine does not typically cause memory loss as a primary adverse effect, though it can cause cognitive impairment in other domains, particularly difficulty with concentration, psychomotor slowing, and speech/language problems. 1

Evidence from FDA Drug Labeling

The FDA-approved labeling for oxcarbazepine clearly identifies cognitive adverse reactions but does not list memory loss as a prominent feature. The cognitive symptoms are categorized into three main types 1:

  1. Cognitive symptoms: psychomotor slowing, difficulty with concentration, and speech or language problems
  2. Somnolence or fatigue
  3. Coordination abnormalities: ataxia and gait disturbances

In clinical trials, 7.1% of oxcarbazepine-treated adults experienced cognitive adverse reactions versus 4% on placebo 1. Notably, the specific cognitive complaint was "concentration impairment" rather than memory deficits.

Clinical Trial Evidence

Adult Studies

The American Academy of Neurology/American Epilepsy Society guidelines from 2004 reviewed class I evidence for oxcarbazepine in refractory epilepsy 2. The most frequent adverse events identified were:

  • Somnolence
  • Dizziness
  • Headache
  • Ataxia
  • Nausea
  • Vomiting

Memory loss was not listed among the adverse events in these large-scale trials, which included 694 patients 2.

Pediatric Studies

In children aged 3-17 years, cognitive adverse events occurred in 5.8% of oxcarbazepine-treated patients, with the single most common event being concentration impairment (4 of 138 patients), not memory problems 1. The most common adverse events in children were somnolence, headache, dizziness, vomiting, and nausea 2.

Comparative Cognitive Studies

A 2006 study directly comparing oxcarbazepine to topiramate found that oxcarbazepine actually improved delayed word recall performance compared to topiramate, which showed worse working memory and verbal fluency 3. This suggests oxcarbazepine may have a relatively favorable cognitive profile regarding memory.

Another 2006 study in children and adolescents found no differences in cognitive tests between oxcarbazepine and carbamazepine/valproate over 6 months 4.

Most compellingly, a 1993 study in healthy volunteers found that oxcarbazepine had no effect on long-term memory processes and actually improved some aspects of psychomotor functioning 5.

Clinical Implications

If a patient on oxcarbazepine reports memory problems, consider:

  • Alternative causes: Epilepsy itself causes memory impairment independent of medication
  • Concentration deficits masquerading as memory problems: Difficulty concentrating (which oxcarbazepine does cause) can present as apparent memory issues
  • Polytherapy effects: Combined antiepileptic drugs increase cognitive side effects
  • Dose-related effects: Higher doses (especially 2,400 mg/day) increase cognitive adverse events

Important Caveats

The cognitive effects are dose-dependent and more pronounced with polytherapy. In the pivotal trial, 65% of patients discontinued at 2,400 mg/day when added to existing antiepileptic drugs due to primarily CNS-related adverse events 1. However, in monotherapy trials at the same dose, discontinuation rates for cognitive adverse events were minimal 1.

Bottom line: Oxcarbazepine causes concentration difficulties and psychomotor slowing, not memory loss per se. If memory complaints arise, investigate other causes before attributing them to oxcarbazepine.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.